Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Intensive care unit readmission during childhood after preterm birth with respiratory failure.

Mourani PM, Kinsella JP, Clermont G, Kong L, Perkins AM, Weissfeld L, Cutter G, Linde-Zwirble WT, Abman SH, Angus DC, Watson RS; Prolonged Outcomes after Nitric Oxide (PrONOx) Investigators.

J Pediatr. 2014 Apr;164(4):749-755.e3. doi: 10.1016/j.jpeds.2013.11.062. Epub 2013 Dec 31.

2.

Evidence of galaxy cluster motions with the kinematic Sunyaev-Zel'dovich effect.

Hand N, Addison GE, Aubourg E, Battaglia N, Battistelli ES, Bizyaev D, Bond JR, Brewington H, Brinkmann J, Brown BR, Das S, Dawson KS, Devlin MJ, Dunkley J, Dunner R, Eisenstein DJ, Fowler JW, Gralla MB, Hajian A, Halpern M, Hilton M, Hincks AD, Hlozek R, Hughes JP, Infante L, Irwin KD, Kosowsky A, Lin YT, Malanushenko E, Malanushenko V, Marriage TA, Marsden D, Menanteau F, Moodley K, Niemack MD, Nolta MR, Oravetz D, Page LA, Palanque-Delabrouille N, Pan K, Reese ED, Schlegel DJ, Schneider DP, Sehgal N, Shelden A, Sievers J, Sifón C, Simmons A, Snedden S, Spergel DN, Staggs ST, Swetz DS, Switzer ER, Trac H, Weaver BA, Wollack EJ, Yeche C, Zunckel C.

Phys Rev Lett. 2012 Jul 27;109(4):041101. Epub 2012 Jul 23.

PMID:
23006072
3.

Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing.

Reader JC, Matthews TP, Klair S, Cheung KM, Scanlon J, Proisy N, Addison G, Ellard J, Piton N, Taylor S, Cherry M, Fisher M, Boxall K, Burns S, Walton MI, Westwood IM, Hayes A, Eve P, Valenti M, de Haven Brandon A, Box G, van Montfort RL, Williams DH, Aherne GW, Raynaud FI, Eccles SA, Garrett MD, Collins I.

J Med Chem. 2011 Dec 22;54(24):8328-42. doi: 10.1021/jm2007326. Epub 2011 Nov 23.

4.

Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases.

Matthews TP, McHardy T, Klair S, Boxall K, Fisher M, Cherry M, Allen CE, Addison GJ, Ellard J, Aherne GW, Westwood IM, van Montfort R, Garrett MD, Reader JC, Collins I.

Bioorg Med Chem Lett. 2010 Jul 15;20(14):4045-9. doi: 10.1016/j.bmcl.2010.05.096. Epub 2010 May 27.

PMID:
20561787
5.

Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 year.

Watson RS, Clermont G, Kinsella JP, Kong L, Arendt RE, Cutter G, Linde-Zwirble WT, Abman SH, Angus DC; Prolonged Outcomes After Nitric Oxide Investigators.

Pediatrics. 2009 Nov;124(5):1333-43. doi: 10.1542/peds.2009-0114. Epub 2009 Oct 19.

PMID:
19841128
6.

Ethics committees: we all need research ethics committees.

Addison GM.

BMJ. 2006 Mar 25;332(7543):730. No abstract available.

7.

Long-term outcome of meningococcal sepsis-associated acute renal failure.

Slack R, Hawkins KC, Gilhooley L, Addison GM, Lewis MA, Webb NJ.

Pediatr Crit Care Med. 2005 Jul;6(4):477-9.

PMID:
15982443
8.

Longitudinal study of thyroid function in Down's syndrome in the first two decades.

Gibson PA, Newton RW, Selby K, Price DA, Leyland K, Addison GM.

Arch Dis Child. 2005 Jun;90(6):574-8.

9.

Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Thomas PD, Forbes A, Green J, Howdle P, Long R, Playford R, Sheridan M, Stevens R, Valori R, Walters J, Addison GM, Hill P, Brydon G.

Gut. 2003 Jul;52 Suppl 5:v1-15. No abstract available.

10.

Does adjustment of GFR to extracellular fluid volume improve the clinical utility of cystatin C?

Kilpatrick ES, Keevil BG, Addison GM.

Arch Dis Child. 2000 Jun;82(6):499-502.

11.

Prenatal origin of acute lymphoblastic leukaemia in children.

Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G, Saha V, Biondi A, Greaves MF.

Lancet. 1999 Oct 30;354(9189):1499-503.

PMID:
10551495
12.

Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.

Lord J, Thomason MJ, Littlejohns P, Chalmers RA, Bain MD, Addison GM, Wilcox AH, Seymour CA.

J Epidemiol Community Health. 1999 Mar;53(3):179-86.

13.

Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose.

Kilpatrick ES, Keevilt BG, Richmond KL, Newland P, Addison GM.

Diabet Med. 1999 Jun;16(6):496-9.

PMID:
10391398
14.

Linear growth in prepubertal children with atopic dermatitis.

Patel L, Clayton PE, Addison GM, Price DA, David TJ.

Arch Dis Child. 1998 Aug;79(2):169-72.

15.

A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism.

Thomason MJ, Lord J, Bain MD, Chalmers RA, Littlejohns P, Addison GM, Wilcox AH, Seymour CA.

J Public Health Med. 1998 Sep;20(3):331-43. Review.

16.

Sudden infant death syndrome (SIDS): the search for the cause.

Addison GM.

J Clin Pathol. 1998 Jun;51(6):419. No abstract available.

17.

Urinary IGF and IGF binding protein-3 in children with disordered growth. The North West Paediatric Endocrine Group.

Gill MS, Whatmore AJ, Tillman V, White A, Addison GM, Price DA, Clayton PE.

Clin Endocrinol (Oxf). 1997 Apr;46(4):483-92.

PMID:
9196612
18.

Newborn screening for inborn errors of metabolism: a systematic review.

Seymour CA, Thomason MJ, Chalmers RA, Addison GM, Bain MD, Cockburn F, Littlejohns P, Lord J, Wilcox AH.

Health Technol Assess. 1997;1(11):i-iv, 1-95. Review.

20.

Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets.

Patel L, Clayton PE, Brain C, Pelekouda E, Addison GM, Price DA, Mughal MZ.

Clin Endocrinol (Oxf). 1996 Jun;44(6):687-96.

PMID:
8759181
Items per page

Supplemental Content

Loading ...
Write to the Help Desk